Last10K.com

Galapagos Nv (GLPG) SEC Filing 20-F Annual report for the fiscal year ending Thursday, December 31, 2020

Galapagos Nv

HISTORY TOOLS
CIK: 1421876 Ticker: GLPG

View differences made from one year to another to evaluate Galapagos Nv's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Galapagos Nv.

Continue

Assess how Galapagos Nv's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Galapagos Nv's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Document And Entity Information
Consolidated Statement Of Cash Flows
Consolidated Statement Of Cash Flows, Current Financial Investments
Consolidated Statement Of Changes In Equity
Consolidated Statement Of Comprehensive Income/Loss (-)
Consolidated Statement Of Financial Position
Consolidated Statement Of Operations
Auditor's Remuneration
Auditor's Remuneration (Details)
Cash And Cash Equivalents
Cash And Cash Equivalents (Details)
Cash And Cash Equivalents (Tables)
Cash And Cash Equivalents - Narrative (Details)
Consolidated Companies As Of December 31, 2020
Consolidated Companies As Of December 31, 2020 (Details)
Consolidated Companies As Of December 31, 2020 (Tables)
Contingent Assets And Liabilities
Contingent Assets And Liabilities (Details)
Critical Accounting Judgments And Key Sources Of Estimation Uncertainty
Critical Accounting Judgments And Key Sources Of Estimation Uncertainty - Ifrs 15 ??? Revenue Recognition Gilead (Details)
Current Financial Investments
Current Financial Investments (Details)
Deferred Income
Deferred Income (Details)
Deferred Income (Tables)
Deferred Income - Movement In The Non-Current And Current Deferred Income (Details)
Deferred Tax
Deferred Tax (Tables)
Deferred Tax - Narrative (Details)
Deferred Tax - Summary Of Deferred Tax Assets And Liabilities (Details)
Discontinued Operations
Discontinued Operations (Details)
Discontinued Operations (Tables)
Discontinued Operations - Assets And Liabilities (Details 2)
Discontinued Operations - Assets And Liabilities (Details)
Discontinued Operations - Financial Performance (Details)
Events After Balance Sheet Date
Events After Balance Sheet Date (Details)
Fair Value Re-Measurement Of Share Subscription Agreement And Warrants Granted To Gilead
Fair Value Re-Measurement Of Share Subscription Agreement And Warrants Granted To Gilead (Tables)
Fair Value Re-Measurement Of Share Subscription Agreement And Warrants Granted To Gilead - Financial Assets (Details)
Financial Risk Management
Financial Risk Management (Tables)
Financial Risk Management - Aging Of Debtors (Details)
Financial Risk Management - Financial Risk Factors (Details)
Financial Risk Management - Interest Rate Risk And Foreign Exchange Risk (Details)
General Information
General Information (Details)
Income Taxes
Income Taxes (Tables)
Income Taxes - Narrative (Details)
Income Taxes - Schedule Of Tax Liabilities (Details)
Income Taxes - Summary Of Income Tax Recognized (Details)
Income Taxes - Summary Of Income Tax Reconciliation (Details)
Income/Loss (-) Per Share
Income/Loss (-) Per Share (Details)
Income/Loss (-) Per Share (Tables)
Intangible Assets
Intangible Assets (Details)
Intangible Assets (Tables)
Lease Liabilities
Lease Liabilities (Details)
Lease Liabilities (Tables)
Off-Balance Sheet Arrangements
Off-Balance Sheet Arrangements (Details)
Off-Balance Sheet Arrangements (Tables)
Operating Cash Flow
Operating Cash Flow (Details)
Operating Cash Flow (Tables)
Operating Costs
Operating Costs (Tables)
Operating Costs - Summary Of General And Administrative Expenses (Details)
Operating Costs - Summary Of Research And Development Expenditure (Details)
Operating Costs - Summary Of Research And Development Expenditure By Program (Details)
Operating Costs - Summary Of Sales And Marketing Expenses (Details)
Other Financial Income / Expenses
Other Financial Income / Expenses (Details)
Other Financial Income / Expenses (Tables)
Other Non-Current Assets
Other Non-Current Assets (Tables)
Other Non-Current Assets - Financial Assets Held At Fair Value Through Profit Or Loss (Details)
Other Non-Current Assets - Summary (Details)
Property, Plant And Equipment
Property, Plant And Equipment (Tables)
Property, Plant And Equipment - Carrying Amount (Details)
Property, Plant And Equipment - Fully Owned (Details)
Property, Plant And Equipment - Right Of Use (Details)
Related Parties
Related Parties (Tables)
Related Parties - Narrative (Details)
Related Parties - Summary Of Remuneration Package (Details)
Research And Development Incentives Receivables
Research And Development Incentives Receivables (Tables)
Research And Development Incentives Receivables - Current And Non-Current (Details)
Research And Development Incentives Receivables - Maturities (Details)
Segment Information
Segment Information (Details)
Segment Information (Tables)
Segment Information - Major Customers (Details)
Segment Information - Non-Current Assets By Location (Details)
Share Based Payments
Share Based Payments (Tables)
Share Based Payments - Category (Details)
Share Based Payments - Restricted Stock Units (Rsu's) (Details Textual)
Share Based Payments - Restricted Stock Units - Category (Details)
Share Based Payments - Restricted Stock Units - Rollforward (Details)
Share Based Payments - Rollforward (Details)
Share Based Payments - Subscription Right Plans (Details Textual)
Share Based Payments - Summary Of Rsu's Outstanding (Details)
Share Based Payments - Summary Of Subscription Rights Outstanding And Exercisable (Details)
Share Based Payments - Valuation (Details)
Share Capital
Share Capital (Tables)
Share Capital - Capital Increase (Details)
Share Capital - History (Details)
Share Capital - History - Narrative (Details)
Share Capital - Other Information (Details)
Share Capital - Reconciliation (Details)
Significant Accounting Policies
Significant Accounting Policies (Details)
Significant Accounting Policies (Policies)
Significant Accounting Policies (Tables)
Significant Accounting Policies - Employee Benefits (Details)
Significant Accounting Policies - Intangible Assets (Details)
Significant Accounting Policies - Property, Plant And Equipment (Details)
Significant Accounting Policies - Segment Reporting (Details)
Staff Costs
Staff Costs (Details)
Staff Costs (Tables)
Summary Of Significant Transaction
Summary Of Significant Transaction (Details)
Total Revenues And Other Income
Total Revenues And Other Income (Tables)
Total Revenues And Other Income - Allocation Of Transaction Price (Details)
Total Revenues And Other Income - Disaggregation Of Revenues (Details)
Total Revenues And Other Income - Revenue By Collaboration And By Category Of Revenue (Details)
Total Revenues And Other Income - Schedule Of The Revenue Recognition Of Upfront Payments, License Fees And Milestone Payments And The Impact Of The Adoption Of Ifrs 15 (Details)
Total Revenues And Other Income - Summary Of Other Income (Details)
Trade And Other Liabilities
Trade And Other Liabilities (Details)
Trade And Other Liabilities (Tables)
Trade And Other Receivables And Other Current Assets
Trade And Other Receivables And Other Current Assets (Details)
Trade And Other Receivables And Other Current Assets (Tables)
Ticker: GLPG
CIK: 1421876
Form Type: 20-F Annual Report
Accession Number: 0001554855-21-000053
Submitted to the SEC: Thu Mar 25 2021 4:21:54 PM EST
Accepted by the SEC: Thu Mar 25 2021
Period: Thursday, December 31, 2020
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/glpg/0001554855-21-000053.htm